In summary, the current study demonstrated that the implementation of UG-FNAB and BRAF p.V600E genetic testing in Qilu Hospital significantly improved the malignancy rate in thyroid surgery, reduced unnecessary surgical treatment, and optimized the initial treatment of thyroid cancer. The gene discussed is BRAF; the disease is thyroid gland carcinoma.